Get the Stockscreener App
0.9908
2.86%
-0.0292
After Hours:
.98
-0.0108
-1.09%
Polyrizon Ltd stock is traded at $0.9908, with a volume of 199.78K.
It is down -2.86% in the last 24 hours and down -9.10% over the past month.
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
See More
Previous Close:
$1.02
Open:
$1.02
24h Volume:
199.78K
Relative Volume:
0.18
Market Cap:
$5.93M
Revenue:
-
Net Income/Loss:
$-1.13M
P/E Ratio:
-0.0173
EPS:
-57.1626
Net Cash Flow:
$-2.63M
1W Performance:
-9.10%
1M Performance:
-9.10%
6M Performance:
-99.61%
1Y Performance:
-99.66%
1-Day Range:
$0.96
$1.02
1-Week Range:
$0.96
$1.09
52-Week Range:
$0.55
$1,200.00
Polyrizon Ltd Stock (PLRZ) Company Profile
Compare PLRZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLRZ
Polyrizon Ltd
|
0.9908 | 6.11M | 0 | -1.13M | -2.63M | -57.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Polyrizon Ltd Stock (PLRZ) Latest News
Can trapped investors hope for a rebound in Polyrizon Ltd.Price Action & Precise Trade Entry Recommendations - newser.com
Can Polyrizon Ltd. stock hit record highs againShort Setup & Weekly High Conviction Trade Ideas - newser.com
Is Polyrizon Ltd. stock attractive for long term wealth buildingPortfolio Value Report & Real-Time Market Trend Scan - newser.com
What indicators show strength in Polyrizon Ltd.Wall Street Watch & Risk Managed Investment Signals - newser.com
Will Polyrizon Ltd. stock deliver consistent dividendsJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
What Fibonacci levels say about Polyrizon Ltd. reboundEarnings Growth Report & Real-Time Chart Breakout Alerts - newser.com
Can Polyrizon Ltd. stock hit analyst price targets2025 Sector Review & Fast Moving Stock Watchlists - newser.com
Can Polyrizon Ltd. stock deliver consistent earnings growth2025 Price Momentum & Free Growth Oriented Trading Recommendations - newser.com
Is Polyrizon Ltd. stock gaining market shareTreasury Yields & Proven Capital Preservation Tips - newser.com
Is Polyrizon Ltd. a candidate for recovery play2025 Market Trends & AI Forecasted Entry and Exit Points - newser.com
How to integrate Polyrizon Ltd. into portfolio analysis toolsJuly 2025 Outlook & Daily Volume Surge Signals - newser.com
Multi asset correlation models including Polyrizon Ltd.2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
News impact scoring models applied to Polyrizon Ltd.Long Setup & Weekly Return Optimization Plans - newser.com
How to build a custom watchlist for Polyrizon Ltd.July 2025 Market Mood & Weekly Momentum Picks - newser.com
Can Polyrizon Ltd. stock beat market expectations this quarterQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
Predicting Polyrizon Ltd. trend using moving averages2025 Technical Overview & Real-Time Buy Signal Alerts - newser.com
How Polyrizon Ltd. stock reacts to Fed rate cutsDividend Hike & Verified Trade Idea Suggestions - newser.com
What MACD signals say about Polyrizon Ltd.Global Markets & High Accuracy Buy Signal Tips - newser.com
Polyrizon Ltd Stock (PLRZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):